It’s been a wild few months for the cannabis industry. Between Canopy Growth’s (TSX:WEED)(NYSE:CGC) $5 billion deal, a late summer mega-rally, and October’s sharp sell-off, there’s been more news about this sector than any other as of late.
But now, a lot of traders think the party is over. According to research by S3 partners, total short positions in pot stocks rose to $3.53 billion since the middle of the year, indicating dimming investor sentiment toward this asset class. While some pot stocks remain up this year, most are approaching 12-month lows. The list includes Canopy, which traded for $45.14 at the time of this writing — frighteningly close to its pre-summer peak of $42.07.
What explains the rise in traders shorting pot stocks?
Pot stocks have been falling since early October, and there’s no end in sight. Canopy is down 38% since its October 15th high. Aurora Cannabis has fallen 50% in the same period. Some of the smaller-cap pot stocks fell less dramatically, but I can’t find a single TSX-listed pot stock that’s up since October 15. Granted, some of this can be explained by a broader TSX sell-off. But cannabis stocks are down even more than the TSX average. What’s going on here?
Continued financial woes
One major problem in the cannabis sector lies in the earnings department. Although most pot stocks are growing revenue, their expenses are growing even more. This was the case in Canopy’s recent earnings report, where revenue was up 33%, but the net loss ballooned to over $300 million. Some pot stocks, like Aurora, have posted positive net income. But, in most of these cases, the majority of earnings were unrealized non-cash gains on derivatives and securities. In operational terms, they’re still losing money.
Legalization: uncertainties abound
A final concern area for pot stocks is the way legalization was handled. Although legalization most likely increased pot producers’ revenue, the first week of legal pot was marred by supply shortages and fulfillment issues. Many customers reported returning to black market dealers after being disappointed in stores. While it’s likely that supply issues will eventually be sorted out, the fact that many customers are returning to the black market is concerning. It suggests that black market vendors may be able to undermine legitimate cannabis sales in the future, especially if they can offer lower prices. If that turns out to be the case, then cannabis companies may need to start cutting prices to stay competitive.
Cannabis is a fast-growing industry that’s not going anywhere anytime soon. Despite concerns about earnings, most cannabis producers are actually highly profitable as measured by gross profit; the losses we’re seeing come from acquisition costs and bloat elsewhere in the business. The question is whether the fat can be cut enough to turn pot stocks into lean, mean, moneymaking machines. For now, though, it appears the shorters may be on to something.
When you buy heavily cyclical stocks at low prices… and then hold the shares until the cycle reaches its peak… you can make a very healthy profit.
Every investor knows that. But many struggle to identify the best opportunities.
Except The Motley Fool may have a plan to solve that problem! Our in-house analyst team has poured thousands of hours into their proprietary research – and this is the result.
Our top advisor Iain Butler has just identified his #1 stock to buy in 2018 (and beyond).
The last time this stock went from the low point of its cycle to the peak… shares shot from $12 to $40 inside of 4 years. That’s an 300%-plus return. And if you missed out on that ride, today might just be your second chance.
Fool contributor Andrew Button has no position in any of the stocks mentioned.